VANCOUVER, British Columbia & SAN DIEGO--(BUSINESS WIRE)--Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that the company appointed Ronald G. Sosnowski, Ph.D., to Vice President Research & Development. Dr. Sosnowski has more than 25 years of experience in molecular diagnostics and has authored more than 25 patents and journal articles. He was most recently Senior Director, Molecular Biology and Research for Nanogen, a molecular diagnostics and point-of-care testing company.
